CDC7 Kinase Inhibitor BMS-863233
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Protein Kinase Inhibitor ->
Serine Threonine Kinase Inhibitor -> CDC7 Kinase Inhibitor BMS-863233
CDC7 Kinase Inhibitor BMS-863233 Definition
An orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells. CDC7, a serine-threonine kinase overexpressed in a variety of tumor cell types, plays an essential role in the initiation of DNA replication by activating origins of replication.
CDC7 Kinase Inhibitor BMS-863233 Synonyms
CDC7 Kinase Inhibitor BMS-863233, BMS-863233, Cell Division Cycle 7 Homolog Kinase Inhibitor BMS-863233
Terms in CDC7 Kinase Inhibitor BMS-863233 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.